Evaluation of FHIT gene alterations in ovarian cancer
1998

Evaluation of FHIT gene alterations in ovarian cancer

Sample size: 54 publication Evidence: low

Author Information

Author(s): F Buttitta, A Marchetti, O Radil, G Bertaccal, S Pellegrinil, A Gadducci, AR Genazzani, G Bevilacqual

Primary Institution: University of Pisa

Hypothesis

We decided to investigate the role of FHIT in human ovarian tumorigenesis.

Conclusion

The results indicate that FHIT plays a role in a small proportion of ovarian carcinomas.

Supporting Evidence

  • An abnormal transcript of the FHIT gene was found in two cases (4%) and allelic losses in eight cases (15%).
  • Twelve (22%) of the 54 tumours investigated belonged to young patients with a family history of breast/ovarian cancer.
  • Only samples with a high proportion of neoplastic cells were subjected to genetic analysis.

Takeaway

This study looked at a gene called FHIT in ovarian cancer and found that it is only changed in a few cases.

Methodology

Fifty-four primary ovarian carcinomas were studied using reverse transcription of FHIT mRNA followed by PCR amplification and sequencing.

Limitations

The number of cases with FHIT aberrations is too low to draw definitive conclusions.

Participant Demographics

The study included 54 patients, with 42 post-menopausal and 12 young patients with a family history of breast/ovarian cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication